BOSENTAN OPTIONS

In vitro and in vivo proof demonstrating comprehensive hepatic metabolism of bosentan implies that liver impairment could appreciably raise publicity to bosentan.Bosentan is a particular and competitive antagonist at endothelin receptor sorts ETA and ETB. Bosentan has a slightly better affinity for ETA receptors than for ETB receptors. The clinical